GlassScriptPhysician profile
Frank F Ing
NPI 1528153756
$112,932.69
in general payments reported to CMS, 2019-2025
15 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Pediatric Cardiology providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $32K · 2021: $14K · 2022: $8,268 · 2023: $3,962 · 2024: $11K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,650 · Travel and Lodging: $8,371 · Food and Beverage: $5,056 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,650.00 |
| Travel and Lodging | $8,371.13 |
| Food and Beverage | $5,055.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,550.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $89,131.91 | 2019-2025 | Mitraclip, Amplatzer Piccolo, Amplatzer |
| Medtronic, INC. | $8,844.08 | 2022-2025 | Harmony |
| Edwards Lifesciences Corporation | $6,522.88 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System |
| Cordis US Corp. | $6,298.41 | 2021-2025 | |
| Medtronic Vascular, INC. | $1,724.72 | 2019 | |
| Penumbra, INC. | $134.62 | 2023 | Ruby Coil |
| Renata Medical, INC. | $76.67 | 2025 | Minima Stent System - 6mm, Minima Stent System - 8mm |
| Shockwave Medical, INC | $64.41 | 2021-2022 | |
| Merit Medical Systems INC | $35.64 | 2025 | |
| Biotronik INC. | $20.16 | 2019 | |
| Boston Scientific Corporation | $17.96 | 2020 | |
| Biosense Webster, INC. | $17.26 | 2023 | Carto 3 |
| Philips North America LLC | $15.22 | 2022 | |
| Chiesi USA, INC. | $14.63 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Ing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.